retatrutide benefits clinical trial retatrutide Retatrutide: Evidence, Safety & Options Triple hormone receptor agonist retatrutide

GLP-1 drugs treat but do not cure diabetes or obesity they require ongoing use to maintain benefits

Make protein non-negotiable

doi: 10.1111/dme.12328 216 RiddleMCAronsonRHomePMarreMNiemoellerEMiossecPet al

Niraj Choudhary, M.D

To view a copy of this licence, visit About this article Cite this article Go, E.J., Hwang, SM., Jo, H

Retatrutide is a new treatment for those who are overweight or living with obesity The medication has not yet received approval or become available It works by targeting three different receptors at the same time Clinical trials to date suggest potential weight loss of up to 24% Side effects seem to be similar to those seen with other GLP-1 medications About Retatrutide Retatrutide is a new treatment for those who are overweight or living with obesity The medication has not yet received approval or become available It works by targeting three different receptors at the same time Clinical trials to date suggest potential weight loss of up to 24% Side effects seem to be similar to those seen with other GLP-1 medications Retatrutide: new weight loss medication in development Retatrutide is a new medication that is currently attracting considerable attention as a potential treatment for overweight and obesity